Chen, P.,
Yu, Y.,
Su, S.,
Du, Z.,
Cai, B.,
Sun, X.,
Chattipakorn, N.,
Samorodov, A.V.,
Pavlov, V.N.,
Tang, Q.,
Cho, W.-J.,
Liang, G. (2023) in lipopolysaccharide (LPS)-challenged J774A.1 cells.
Compounds 19, 20, and 39 potently reduced the release of IL-6
Gurevich, K.G.,
Urakov, A.L.,
Purygin, P.P.,
Abzalilov, T.A.,
Garaev, T.M.,
Zarubin, Y.P.,
Afanasiev, V.A.,
Sakaev, V.E.,
Samoredov, A.V.,
Pavlov, V.N.,
Lovtsova, L.V. (2023) . It was hypothesized that
compounds synthesized from natural amino acids would possess these pharmacological activities
Khaliullin, F.A.,
Klen, E.E.,
Nikitina, I.L.,
Pavlov, V.N.,
Rozit, G.A.,
Gaisina, G.G.,
Samorodov, A.V. (2023) . The structures of the synthesized
compounds were confirmed by IR, PMR, and 13C and 15N NMR spectroscopy
Khaliullin, F. A.,
Klen, E. E.,
Nikitina, I. L.,
Pavlov, V. N.,
Rozit, G. A.,
Gaisina, G. G.,
Samorodov, A. V. (2023) . The structures
of the synthesized
compounds were confirmed by IR, PMR, and 13C and 15N NMR spectroscopy
Li, Xiang,
Yin, Lina,
Liao, Jing,
Yang, Jun,
Cai, Binhao,
Yu, Yiming,
Su, Sijia,
Du, Zhiteng,
Li, Xiaobo,
Zhou, Ying,
Chen, Pan,
Cho, Won-Jea,
Chattipakorn, Nipon,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhang, Fengzhi,
Liang, Guang,
Tang, Qidong (2023) and synthesized using cinnamic acid as the lead
compound. We tested the preliminary anti-inflammatory activity
-7 breast adenocarcinoma, and SH-SY5Y neuroblastoma cells was studied. The most active
compound